Aakaar Medical Technologies IPO
IPO Listing Details
- Listing Date
27 Jun 2025
- Listing Price
₹ 75.00
- Listing Change
4.17%
- Last Traded Price
₹ 89.75
IPO Details
-
Open Date
20 Jun 2025
-
Close Date
24 Jun 2025
-
Listing Date
27 Jun 2025
- IPO Price Range
₹ 68 to ₹72
- IPO Size
₹ 27 Cr
- Listing Exchange
NSE SME
IPO Timeline
Aakaar Medical Technologies IPO Subscription Status
| Date | QIB | NII | Retail | TOTAL |
|---|---|---|---|---|
| 20-Jun-25 | 0.33 | 0.59 | 0.31 | 0.37 |
| 23-Jun-25 | 0.33 | 0.66 | 0.88 | 0.68 |
| 24-Jun-25 | 0.33 | 0.74 | 1.08 | 0.79 |
Last Updated: 24 June 2025 6:04 PM by 5paisa
Incorporated in 2013, Dilip Ramesh Meswani leads Aakaar Medical Technologies Limited, an aesthetic medical company offering a wide range of specialised cosmetic products and devices. The company supplies to dermatologists, plastic surgeons, and aesthetic physicians across India, with a product portfolio that includes both in-house brands and imported devices from countries such as South Korea, Spain, Italy, and Austria.
Aakaar’s offerings cover homecare skincare, injectables, hair care, medifacial kits, and medical-grade devices like laser hair removal, tattoo removal, and skin rejuvenation equipment. The company has a national presence and a trained team of 90 sales and service professionals serving a wide customer base across multiple states.
Established in: 2013
Managing Director: Dilip Ramesh Meswani
Objectives
The company plans to utilise the net IPO proceeds towards:
1. Funding working capital requirements
2. General corporate purposes
Aakaar Medical Technologies IPO Size
| Types | Size |
|---|---|
| Total IPO Size | ₹27.00 Cr |
| Offer For Sale | - |
| Fresh Issue | ₹27.00Cr |
Aakaar Medical Technologies IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1600 | ₹1,08,800 |
| Retail (Max) | 1 | 1600 | ₹1,08,800 |
| HNI (Min) | 2 | 3200 | ₹2,17,600 |
Aakaar Medical Technologies IPO Reservation
| Investors Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Cr.)* |
|---|---|---|---|---|
| QIB | 3.51 | 7,12,000 | 24,96,000 | 17.971 |
| NII (HNI) | 1.48 | 5,36,000 | 7,93,60 | 5.714 |
| Retail | 1.93 | 12,48,000 | 24,11,200 | 17.361 |
| Total** | 2.28 | 24,96,000 | 57,00,800 | 41.046 |
*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.
| Particulars (in Rs. Crores) | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | 32.88 | 46.27 | 61.76 |
| EBITDA | 3.52 | 5.00 | 9.74 |
| PAT | 2.15 | 2.87 | 6.04 |
| Particulars (in Rs. Crores)] | FY23 | FY24 | FY25 |
|---|---|---|---|
| Total Assets | 5.87 | 15.06 | 22.74 |
| Share Capital | 0.70 | 0.70 | 10.42 |
| Total Borrowings | 23.23 | 34.01 | 51.85 |
| Particulars (in Rs. Crores | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net Cash Generated From / (used in) operating activities | -2.93 | -8.04 | -5.41 |
| Net Cash Generated From / (used in) investing activities | -0.32 | -0.04 | -0.05 |
| Net Cash Generated From / (used in) financing activities | 1.17 | 8.19 | 10.71 |
| Net Increase (Decrease) In Cash And Cash Equivalents | -2.08 | 0.11 | 5.25 |
Strengths
1. Strong promoter and leadership background
2. Pan-India presence through consignment sales
3. Diversified portfolio across skincare, devices, and injectables
4. Growing revenue and profitability metrics
Weakness
1. Negative operational cash flow in the last three years
2. Reliance on limited categories in aesthetic healthcare
3. Total borrowings increased to ₹22.74 Cr by FY25
4. Absence of EBITDA disclosures
Opportunities
1. Rising demand for aesthetic treatments and wellness devices
2. Growth in the dermatology and cosmetic surgery markets in India
3. Strong positioning for expansion into tier-2/3 cities
4. Opportunity to localise production and reduce import costs
Threats
1. Intense competition from global medical device players
2. Regulatory changes in healthcare and cosmetic device approvals
3. Vulnerability to foreign exchange fluctuations due to imports
4. Market volatility may impact valuations post-listing
1. Well-diversified product portfolio in a niche and growing segment
2. Demonstrated YoY revenue and profit growth
3. Plans to utilise IPO funds for working capital, enabling scalability
4. Widespread geographic coverage with trained sales teams
5. Positive shift in PAT and net worth over FY23–FY25
1. Rapid growth driven by lifestyle changes and higher disposable incomes
2. Increased awareness and demand for cosmetic procedures
3. Strong influence of digital outreach and evolving beauty trends
4. Expanding market potential in urban and semi-urban areas
5. Rising preference for non-invasive and semi-invasive aesthetic devices
in 3
easy
steps
Using 5paisa App or
Website
to block Payment
Open Free Demat Account
Be a part of 5paisa community - The first listed discount broker of India.
By proceeding, you agree to all T&C*
FAQs
Aakaar Medical Technologies IPO opens on June 20, 2025 and closes on June 24, 2025.
Aakaar Medical Technologies' IPO size is ₹27.00 crores via a fresh issue of 37.50 lakh shares.
Aakaar Medical Technologies' IPO price band is fixed between ₹68 and ₹72 per share.
To apply for Aakaar Medical Technologies IPO, follow the steps given below:
1. Login to your 5paisa account and select the issue in the current IPO section
2. Enter the number of lots and the price at which you wish to apply for the Aakaar Medical Technologies IPO
3. Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange
You will receive the mandate notification to block funds in your UPI app.
The minimum lot size of Aakaar Medical Technologies IPO is 1,600 shares with a minimum retail investment of ₹1,08,800.
The allotment date of Aakaar Medical Technologies IPO is expected to be finalised on June 25, 2025.
The tentative listing date of Aakaar Medical Technologies IPO is June 27, 2025, on the NSE SME platform.
Indorient Financial Services Ltd is the book-running lead manager of Aakaar Medical Technologies.
Aakaar Medical Technologies' plans to utilise the IPO proceeds towards:
1. Fund working capital requirements
2. Support general corporate purposes